Tatyana Gurlo

Fibril specific, conformation dependent antibodies recognize a generic epitope common to amyloid fibrils and fibrillar oligomers that is absent in prefibrillar oligomers

Elizabeth Head, C. Cotman, L. Breydo, 2007, Molecular Neurodegeneration.

Toxic Human Islet Amyloid Polypeptide (h-IAPP) Oligomers Are Intracellular, and Vaccination to Induce Anti-Toxic Oligomer Antibodies Does Not Prevent h-IAPP–Induced β-Cell Apoptosis in h-IAPP Transgenic Mice

Chia-yu Lin, R. Kayed, C. Glabe, 2007, Diabetes.

Pulsatile Portal Vein Insulin Delivery Enhances Hepatic Insulin Action and Signaling

Claudio Cobelli, Chiara Dalla Man, Satoshi Fujita, 2012, Diabetes.

Evidence for proteotoxicity in beta cells in type 2 diabetes: toxic islet amyloid polypeptide oligomers form intracellularly in the secretory pathway.

H. Reber, O. Hines, C. Glabe, 2010, The American journal of pathology.

Islet amyloid in type 2 diabetes, and the toxic oligomer hypothesis.

P. Butler, T. Gurlo, Tatyana Gurlo, 2008, Endocrine reviews.

Inhibition of human IAPP fibril formation does not prevent beta-cell death: evidence for distinct actions of oligomers and fibrils of human IAPP.

Ralf Langen, S. Jayasinghe, Chia-yu Lin, 2006, American journal of physiology. Endocrinology and metabolism.

Diabetes due to a progressive defect in beta-cell mass in rats transgenic for human islet amyloid polypeptide (HIP Rat): a new model for type 2 diabetes.

M. Carty, W. Soeller, P. Butler, 2004, Diabetes.

Recovery of high-quality RNA from laser capture microdissected human and rodent pancreas

P. Butler, T. Gurlo, A. Matveyenko, 2016, Journal of histotechnology.